| Ident. | Authors (with country if any) | Title |
|---|
| 000161 (2017) |
Jeffrey E. Gershenwald ; Richard A. Scolyer ; Kenneth R. Hess ; Vernon K. Sondak ; Georgina V. Long ; Merrick I. Ross ; Alexander J. Lazar ; Mark B. Faries ; John M. Kirkwood ; Grant A. Mcarthur ; Lauren E. Haydu ; Alexander M M. Eggermont ; Keith T. Flaherty ; Charles M. Balch ; John F. Thompson | Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. |
| 000408 (2017) |
Jedd D. Wolchok ; Vanna Chiarion-Sileni ; Rene Gonzalez ; Piotr Rutkowski ; Jean-Jacques Grob ; C Lance Cowey ; Christopher D. Lao ; John Wagstaff ; Dirk Schadendorf ; Pier F. Ferrucci ; Michael Smylie ; Reinhard Dummer ; Andrew Hill ; David Hogg ; John Haanen ; Matteo S. Carlino ; Oliver Bechter ; Michele Maio ; Ivan Marquez-Rodas ; Massimo Guidoboni ; Grant Mcarthur ; Celeste Lebbé ; Paolo A. Ascierto ; Georgina V. Long ; Jonathan Cebon ; Jeffrey Sosman ; Michael A. Postow ; Margaret K. Callahan ; Dana Walker ; Linda Rollin ; Rafia Bhore ; F Stephen Hodi ; James Larkin | Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. |
| 000987 (2017) |
Manfred P. Lutz ; John R. Zalcberg ; Michel Ducreux ; Daniela Aust ; Marco J. Bruno ; Markus W. Büchler ; Jean-Robert Delpero ; Beat Gloor ; Rob Glynne-Jones ; Werner Hartwig ; Florence Huguet ; Pierre Laurent-Puig ; Florian Lordick ; Patrick Maisonneuve ; Julia Mayerle ; Marc Martignoni ; John Neoptolemos ; Andrew D. Rhim ; Bruno M. Schmied ; Thomas Seufferlein ; Jens Werner ; Jean-Luc Van Laethem ; Florian Otto | 3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer. |
| 000D27 (2017) |
Gaya Spolverato ; Fabio Bagante ; Matthew Weiss ; Sorin Alexandrescu ; Hugo P. Marques ; Luca Aldrighetti ; Shishir K. Maithel ; Carlo Pulitano ; Todd W. Bauer ; Feng Shen ; George A. Poultsides ; Oliver Soubrane ; Guillaume Martel ; Bas Groot Koerkamp ; Alfredo Guglielmi ; Endo Itaru ; Timothy M. Pawlik | Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma. |
| 000D95 (2017) |
Ian Smith ; Denise Yardley ; Howard Burris ; Richard De Boer ; Dino Amadori ; Kristi Mcintyre ; Bent Ejlertsen ; Michael Gnant ; Walter Jonat ; Kathleen I. Pritchard ; Mitch Dowsett ; Lowell Hart ; Susan Poggio ; Lisa Comarella ; Herve Salomon ; Barbara Wamil ; Joyce O'Shaughnessy | Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial. |
| 000E58 (2017) |
Reinhard Dummer ; Dirk Schadendorf ; Paolo A. Ascierto ; Ana Arance ; Caroline Dutriaux ; Anna Maria Di Giacomo ; Piotr Rutkowski ; Michele Del Vecchio ; Ralf Gutzmer ; Mario Mandala ; Luc Thomas ; Lev Demidov ; Claus Garbe ; David Hogg ; Gabriella Liszkay ; Paola Queirolo ; Ernesto Wasserman ; James Ford ; Marine Weill ; L Andres Sirulnik ; Valentine Jehl ; Viviana Boz N ; Georgina V. Long ; Keith Flaherty | Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial. |
| 000E64 (2017) |
Ruth Ladenstein ; Ulrike Pötschger ; Andrew D J. Pearson ; Penelope Brock ; Roberto Luksch ; Victoria Castel ; Isaac Yaniv ; Vassilios Papadakis ; Geneviève Laureys ; Josef Malis ; Walentyna Balwierz ; Ellen Ruud ; Per Kogner ; Henrik Schroeder ; Ana Forjaz De Lacerda ; Maja Beck-Popovic ; Pavel Bician ; Mikl S Garami ; Toby Trahair ; Adela Canete ; Peter F. Ambros ; Keith Holmes ; Mark Gaze ; Günter Schreier ; Alberto Garaventa ; Gilles Vassal ; Jean Michon ; Dominique Valteau-Couanet | Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial. |
| 000F74 (2017) |
Aurélie Mbeutcha ; Morgan Rouprêt ; Ashish M. Kamat ; Pierre I. Karakiewicz ; Nathan Lawrentschuk ; Giacomo Novara ; Jay D. Raman ; Christian Seitz ; Evanguelos Xylinas ; Shahrokh F. Shariat | Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review. |
| 001023 (2017) |
Andrew D. Zelenetz ; Jacqueline C. Barrientos ; Jennifer R. Brown ; Bertrand Coiffier ; Julio Delgado ; Mikl S Egyed ; Paolo Ghia ; Árpád Illés ; Wojciech Jurczak ; Paula Marlton ; Marco Montillo ; Franck Morschhauser ; Alexander S. Pristupa ; Tadeusz Robak ; Jeff P. Sharman ; David Simpson ; Lukáš Smolej ; Eugen Tausch ; Adeboye H. Adewoye ; Lyndah K. Dreiling ; Yeonhee Kim ; Stephan Stilgenbauer ; Peter Hillmen | Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial. |
| 001158 (2017) |
Meletios A. Dimopoulos ; Judith Trotman ; Alessandra Tedeschi ; Jeffrey V. Matous ; David Macdonald ; Constantine Tam ; Olivier Tournilhac ; Shuo Ma ; Albert Oriol ; Leonard T. Heffner ; Chaim Shustik ; Ram N García-Sanz ; Robert F. Cornell ; Carlos Fernández De Larrea ; Jorge J. Castillo ; Miquel Granell ; Marie-Christine Kyrtsonis ; Veronique Leblond ; Argiris Symeonidis ; Efstathios Kastritis ; Priyanka Singh ; Jianling Li ; Thorsten Graef ; Elizabeth Bilotti ; Steven Treon ; Christian Buske | Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial. |
| 001243 (2017) |
Elizabeth M. Swisher ; Kevin K. Lin ; Amit M. Oza ; Clare L. Scott ; Heidi Giordano ; James Sun ; Gottfried E. Konecny ; Robert L. Coleman ; Anna V. Tinker ; David M. O'Malley ; Rebecca S. Kristeleit ; Ling Ma ; Katherine M. Bell-Mcguinn ; James D. Brenton ; Janiel M. Cragun ; Ana Oaknin ; Isabelle Ray-Coquard ; Maria I. Harrell ; Elaina Mann ; Scott H. Kaufmann ; Anne Floquet ; Alexandra Leary ; Thomas C. Harding ; Sandra Goble ; Lara Maloney ; Jeff Isaacson ; Andrew R. Allen ; Lindsey Rolfe ; Roman Yelensky ; Mitch Raponi ; Iain A. Mcneish | Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. |
| 001256 (2017) |
Kristian W. Pajtler ; Stephen C. Mack ; Vijay Ramaswamy ; Christian A. Smith ; Hendrik Witt ; Amy Smith ; Jordan R. Hansford ; Katja Von Hoff ; Karen D. Wright ; Eugene Hwang ; Didier Frappaz ; Yonehiro Kanemura ; Maura Massimino ; Cécile Faure-Conter ; Piergiorgio Modena ; Uri Tabori ; Katherine E. Warren ; Eric C. Holland ; Koichi Ichimura ; Felice Giangaspero ; David Castel ; Andreas Von Deimling ; Marcel Kool ; Peter B. Dirks ; Richard G. Grundy ; Nicholas K. Foreman ; Amar Gajjar ; Andrey Korshunov ; Jonathan Finlay ; Richard J. Gilbertson ; David W. Ellison ; Kenneth D. Aldape ; Thomas E. Merchant ; Eric Bouffet ; Stefan M. Pfister ; Michael D. Taylor | The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. |
| 001339 (2017) |
Stephen J. Luen ; Roberto Salgado ; Stephen Fox ; Peter Savas ; Jennifer Eng-Wong ; Emma Clark ; Astrid Kiermaier ; Sandra M. Swain ; Jose Baselga ; Stefan Michiels ; Sherene Loi | Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study. |
| 001430 (2016) |
Adil I. Daud ; Jedd D. Wolchok ; Caroline Robert ; Wen-Jen Hwu ; Jeffrey S. Weber ; Antoni Ribas ; F Stephen Hodi ; Anthony M. Joshua ; Richard Kefford ; Peter Hersey ; Richard Joseph ; Tara C. Gangadhar ; Roxana Dronca ; Amita Patnaik ; Hassane Zarour ; Charlotte Roach ; Grant Toland ; Jared K. Lunceford ; Xiaoyun Nicole Li ; Kenneth Emancipator ; Marisa Dolled-Filhart ; S Peter Kang ; Scot Ebbinghaus ; Omid Hamid | Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma. |
| 001535 (2016) |
Valerie W. Rusch ; Kari Chansky ; Hedy L. Kindler ; Anna K. Nowak ; Harvey I. Pass ; David C. Rice ; Lynn Shemanski ; Françoise Galateau-Sallé ; Brian C. Mccaughan ; Takashi Nakano ; Enrico Ruffini ; Jan P. Van Meerbeeck ; Masahiro Yoshimura | The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma. |
| 001656 (2016) |
Gabriel N. Hortobagyi ; Salomon M. Stemmer ; Howard A. Burris ; Yoon-Sim Yap ; Gabe S. Sonke ; Shani Paluch-Shimon ; Mario Campone ; Kimberly L. Blackwell ; Fabrice André ; Eric P. Winer ; Wolfgang Janni ; Sunil Verma ; Pierfranco Conte ; Carlos L. Arteaga ; David A. Cameron ; Katarina Petrakova ; Lowell L. Hart ; Cristian Villanueva ; Arlene Chan ; Erik Jakobsen ; Arnd Nusch ; Olga Burdaeva ; Eva-Maria Grischke ; Emilio Alba ; Erik Wist ; Norbert Marschner ; Anne M. Favret ; Denise Yardley ; Thomas Bachelot ; Ling-Ming Tseng ; Sibel Blau ; Fengjuan Xuan ; Farida Souami ; Michelle Miller ; Caroline Germa ; Samit Hirawat ; Joyce O'Shaughnessy | Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. |
| 001723 (2016) |
T W Rice ; T E M R. Lerut ; M B Orringer ; L-Q Chen ; W L Hofstetter ; B M Smithers ; V W Rusch ; J. Van Lanschot ; K N Chen ; A R Davies ; X B D'Journo ; K A Kesler ; J D Luketich ; M K Ferguson ; J V R S Nen ; R. Van Hillegersberg ; W. Fang ; L. Durand ; W H Allum ; I. Cecconello ; R J Cerfolio ; M. Pera ; S M Griffin ; R. Burger ; J-F Liu ; M S Allen ; S. Law ; T J Watson ; G E Darling ; W J Scott ; A. Duranceau ; C E Denlinger ; P H Schipper ; H. Ishwaran ; C. Apperson-Hansen ; L M Dipaola ; M E Semple ; E H Blackstone | Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data. |
| 001761 (2016) |
Carolina Bonilla ; Sarah J. Lewis ; Mari-Anne Rowlands ; Tom R. Gaunt ; George Davey Smith ; David Gunnell ; Tom Palmer ; Jenny L. Donovan ; Freddie C. Hamdy ; David E. Neal ; Rosalind Eeles ; Doug Easton ; Zsofia Kote-Jarai ; Ali Amin Al Olama ; Sara Benlloch ; Kenneth Muir ; Graham G. Giles ; Fredrik Wiklund ; Henrik Grönberg ; Christopher A. Haiman ; Johanna Schleutker ; B Rge G. Nordestgaard ; Ruth C. Travis ; Nora Pashayan ; Kay-Tee Khaw ; Janet L. Stanford ; William J. Blot ; Stephen Thibodeau ; Christiane Maier ; Adam S. Kibel ; Cezary Cybulski ; Lisa Cannon-Albright ; Hermann Brenner ; Jong Park ; Radka Kaneva ; Jyotsna Batra ; Manuel R. Teixeira ; Hardev Pandha ; Mark Lathrop ; Richard M. Martin ; Jeff M P. Holly | Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels. |
| 001800 (2016) |
T W Rice ; C. Apperson-Hansen ; L M Dipaola ; M E Semple ; T E M R. Lerut ; M B Orringer ; L-Q Chen ; W L Hofstetter ; B M Smithers ; V W Rusch ; B P L. Wijnhoven ; K N Chen ; A R Davies ; X B D'Journo ; K A Kesler ; J D Luketich ; M K Ferguson ; J V R S Nen ; R. Van Hillegersberg ; W. Fang ; L. Durand ; W H Allum ; I. Cecconello ; R J Cerfolio ; M. Pera ; S M Griffin ; R. Burger ; J-F Liu ; M S Allen ; S. Law ; T J Watson ; G E Darling ; W J Scott ; A. Duranceau ; C E Denlinger ; P H Schipper ; H. Ishwaran ; E H Blackstone | Worldwide Esophageal Cancer Collaboration: clinical staging data. |
| 001801 (2016) |
T W Rice ; L-Q Chen ; W L Hofstetter ; B M Smithers ; V W Rusch ; B P L. Wijnhoven ; K L Chen ; A R Davies ; X B D'Journo ; K A Kesler ; J D Luketich ; M K Ferguson ; J V R S Nen ; R. Van Hillegersberg ; W. Fang ; L. Durand ; I. Cecconello ; W H Allum ; R J Cerfolio ; M. Pera ; S M Griffin ; R. Burger ; J-F Liu ; M S Allen ; S. Law ; T J Watson ; G E Darling ; W J Scott ; A. Duranceau ; C E Denlinger ; P H Schipper ; T E M R. Lerut ; M B Orringer ; H. Ishwaran ; C. Apperson-Hansen ; L M Dipaola ; M E Semple ; E H Blackstone | Worldwide Esophageal Cancer Collaboration: pathologic staging data. |
| 001839 (2016) |
Cyrille Hulin ; Andrew Belch ; Chaim Shustik ; Maria Teresa Petrucci ; Ulrich Dührsen ; Jin Lu ; Kevin Song ; Philippe Rodon ; Brigitte Pégourié ; Laurent Garderet ; Hannah Hunter ; Isabelle Azais ; Richard Eek ; Heinz Gisslinger ; Margaret Macro ; Shaker Dakhil ; Cristina Goncalves ; Richard Leblanc ; Ken Romeril ; Bruno Royer ; Chantal Doyen ; Xavier Leleu ; Fritz Offner ; Nicolas Leupin ; Vanessa Houck ; Guang Chen ; Annette Ervin-Haynes ; Meletios A. Dimopoulos ; Thierry Facon | Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial. |
